Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

IRC002 Study Team, IRC002 Study Team

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study'. Together they form a unique fingerprint.

Medicine & Life Sciences